Organic Process Research & Development 2008, 12, 1261–1264
Technical Notes
Practical Amination of Nitropyridones by Silylation
Robert A. Singer* and Michae¨l Dore´
Chemical Research and DeVelopment, Pfizer Global Research and DeVelopment, Groton Laboratories, Eastern Point Road,
Groton, Connecticut 06340, U.S.A.
Scheme 1. General route to azabenzimidazoles (5) via
4-amino-3-nitropyridine (3)
Abstract:
A practical method for coupling nitropyridones (1) with primary
amines by treatment with hexamethyldisilazane has been devel-
oped, avoiding the use of hazardous reagents such as POCl3. The
activation of the pyridone by a nitro group is necessary for efficient
coupling, leading to aminonitropyridines (3) in good yields.
Regioisomers other than 3-nitro-4-pyridone (1) were found to be
substantially less reactive but would undergo coupling with
primary amines.
and found that primary amines coupled readily with 1b in
isopropanol under ambient conditions to furnish 3a-d in good
isolated yields (Table 1). Upon reaction completion, the products
crystallized following addition of water to the reaction mixture.
While this was a viable process alternative to using the
corresponding chloronitropyridine, the desired methoxynitro-
pyridines were not as readily available nor as inexpensive as
the corresponding hydroxy-substituted derivatives.7
Introduction
During our process research and development work on
potential drug candidates in early development, we encountered
the need to prepare various aminonitropyridines (3) as precursors
for azabenzimidazoles (5). Originally we used a conventional
approach to prepare this family of compounds by displacement
of a chloronitropyridine (2) with the appropriate primary
alkylamine (Scheme 1).1 The chloronitropyridine was prepared
from the corresponding nitropyridone (1) with POCl3.1,2 Since
2 and some chloronitropyridine derivatives are irritants and
potential sensitizers,3 we elected to utilize more benign starting
materials that would be sufficiently activated to undergo
substitution. Herein we describe the process research and
development of a safer activation of nitropyridones to enable
coupling with primary amines.
8
In order to avoid the use of POCl3 and a separate
activation step of the nitropyridones, we explored the use
of hexamethyldisilazane (HMDS). We speculated that
HMDS could be sufficient to carry out in situ activation
(4) (a) Mugnaini, C.; Petricci, E.; Botta, M.; Corelli, F.; Mastromarino,
P.; Giorgi, G. Eur. J. Med. Chem. 2007, 42, 256–262. (b) Cain, G. A.;
Beck, J. P. Heterocycles 2001, 55, 439–446. (c) Zhao, H.; Serby,
M. D.; Xin, Z.; Szczepankiewicz, B. G.; Liu, M.; Kosogof, C.; Liu,
B.; Nelson, L. T. J.; Johnson, E. F.; Wang, S.; Pederson, T.; Gum,
R. J.; Clampit, J. E.; Haasch, D. L.; Abad-Zapatero, C.; Fry, E. H.;
Rondinone, C.; Trevillyan, J. M.; Sham, H. L.; Liu, G. J. Med. Chem.
2006, 49, 4455–4458.
Results and Discussion
Aside from the conversion of 1 to a halide such as 2, other
conventional approaches to the activation of nitropyridone (1)
include the formation of the sulfonate4 or phosphonium salts.5
While these options were likely to be viable, they still utilized
hazardous or toxic reagents. As another option, we were
intrigued by reports in the literature2,6 that methoxynitropyridines
had demonstrated the ability to undergo substitution with
primary amines. We explored the viability of this substrate class
(5) Phosphonium salts have often been formed with reagents such as BOP,
see: (a) Kang, F.-A.; Kodah, J.; Guan, Q.; Li, X.; Murray, W. V. J.
Org. Chem. 2005, 70, 1957–1960. (b) Wan, Z.-K.; Binnum, E.; Wilson,
D. P.; Lee, J. Org. Lett. 2005, 7, 5877–5880. (c) Wan, Z.-K.;
Wacharasindhu, S.; Binnum, E.; Mansour, T. Org. Lett. 2006, 8, 2425–
2428.
(6) (a) Bamford, M. J.; Alberti, M. J.; Bailey, N.; Davies, S.; Dean, D. K.;
Gaiba, A.; Garland, S.; Harling, J. D.; Jung, D. K.; Panchal, T. A.;
Parr, C. A.; Steadman, J. G.; Takle, A. K.; Townsend, J. T.; Wilson,
D. M.; Witherington, J. Bioorg. Med. Chem. Lett. 2005, 15, 3402–
3406. (b) Lanza, T. J.; Durette, P. L.; Rollins, T.; Siciliano, S.;
Cianciarulo, D. N.; Kobayashi, S. V.; Caldwell, C. G.; Springer, M. S.;
Hagmann, W. K. J. Med. Chem. 1992, 35, 252–258.
* Author to whom correspondence may be sent. E-mail:
robert.a.singer@pfizer.com.
(1) Crey-Desiolles, C.; Kotera, M. Bioorg. Med. Chem. 2006, 14, 1935–
1941.
(7) The price of 4-methoxy-3-nitropyridine is about $5/g to $20/g in cost
(depending on the choice of supplier) while the corresponding
hydroxypyridine is about $1/g to $4/g. In addition we had issues with
the quality of 4-methoxy-3-nitropyridine; one supplier provided
samples contaminated with up to 50% of N-methyl-3-nitro-4-pyridone.
(8) POCl3 can be hazardous for both laboratory use and the environment,
see: (a) Kapias, T.; Griffiths, R. F. J. Hazard. Mater. 2001, 81, 223–
249.
(2) Provencal, D. P.; Gesenberg, K. D.; Wang, H.; Escobar, C.; Wong,
H.; Brown, M. A.; Staab, A. J.; Pendri, Y. R. Org. Process Res. DeV.
2004, 8, 903–908.
(3) Material Safety Data Sheets on 2-chloro-3-nitropyridine and 4-chloro-
3-nitropyridine indicate that these materials are severe irritants and
that the 2-chloro isomer is a skin sensitizer.
10.1021/op800201u CCC: $40.75
Published on Web 11/07/2008
2008 American Chemical Society
Vol. 12, No. 6, 2008 / Organic Process Research & Development
•
1261